INOVIQ Ltd
ASX:IIQ

Watchlist Manager
INOVIQ Ltd Logo
INOVIQ Ltd
ASX:IIQ
Watchlist
Price: 0.36 AUD 1.41% Market Closed
Market Cap: AU$50.7m

Relative Value

The Relative Value of one IIQ stock under the Base Case scenario is hidden AUD. Compared to the current market price of 0.36 AUD, INOVIQ Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

IIQ Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

IIQ Competitors Multiples
INOVIQ Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
AU
INOVIQ Ltd
ASX:IIQ
50.7m AUD 55.3 -7 -5.1 -5.1
US
CVS Health Corp
NYSE:CVS
90.9B USD 0.2 51.4 13.4 13.4
US
Cigna Group
XMUN:CGN
67.4B EUR 0.3 13.1 7.7 9.8
US
Cigna Corp
NYSE:CI
69.2B USD 0.3 11.6 0 0
DE
Fresenius SE & Co KGaA
XETRA:FRE
24.6B EUR 1.1 19.4 9.3 13.8
DE
Fresenius Medical Care AG
XMUN:FME
22.5B EUR 1.1 23 8.9 16.4
US
Laboratory Corporation of America Holdings
NYSE:LH
21.6B USD 1.5 24.6 11.9 17.2
US
Quest Diagnostics Inc
NYSE:DGX
21.5B USD 1.9 21.7 11.8 15.9
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
10.5B EUR 0.5 10.8 5.2 9.7
US
Guardant Health Inc
NASDAQ:GH
11.1B USD 11.3 -26.7 -29.3 -26.6
US
DaVita Inc
NYSE:DVA
10.2B USD 0.8 13.7 7.1 9.7
P/E Multiple
Earnings Growth PEG
AU
INOVIQ Ltd
ASX:IIQ
Average P/E: 21.1
Negative Multiple: -7
N/A N/A
US
CVS Health Corp
NYSE:CVS
51.4
90%
0.6
US
C
Cigna Group
XMUN:CGN
13.1
19%
0.7
US
Cigna Corp
NYSE:CI
11.6
19%
0.6
DE
Fresenius SE & Co KGaA
XETRA:FRE
19.4
26%
0.7
DE
Fresenius Medical Care AG
XMUN:FME
23
16%
1.4
US
Laboratory Corporation of America Holdings
NYSE:LH
24.6
27%
0.9
US
Quest Diagnostics Inc
NYSE:DGX
21.7
12%
1.8
DE
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
10.8
16%
0.7
US
Guardant Health Inc
NASDAQ:GH
Negative Multiple: -26.7 N/A N/A
US
DaVita Inc
NYSE:DVA
13.7
20%
0.7
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
AU
INOVIQ Ltd
ASX:IIQ
Average EV/EBITDA: 9.4
Negative Multiple: -5.1
N/A N/A
US
CVS Health Corp
NYSE:CVS
13.4
28%
0.5
US
C
Cigna Group
XMUN:CGN
7.7
4%
1.9
US
Cigna Corp
NYSE:CI
Not Available N/A N/A
DE
Fresenius SE & Co KGaA
XETRA:FRE
9.3
10%
0.9
DE
Fresenius Medical Care AG
XMUN:FME
8.9
7%
1.3
US
Laboratory Corporation of America Holdings
NYSE:LH
11.9
10%
1.2
US
Quest Diagnostics Inc
NYSE:DGX
11.8
6%
2
DE
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
5.2
7%
0.7
US
Guardant Health Inc
NASDAQ:GH
Negative Multiple: -29.3 N/A N/A
US
DaVita Inc
NYSE:DVA
7.1
4%
1.8
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
AU
INOVIQ Ltd
ASX:IIQ
Average EV/EBIT: 13.2
Negative Multiple: -5.1
N/A N/A
US
CVS Health Corp
NYSE:CVS
13.4
22%
0.6
US
C
Cigna Group
XMUN:CGN
9.8
5%
2
US
Cigna Corp
NYSE:CI
Not Available N/A N/A
DE
Fresenius SE & Co KGaA
XETRA:FRE
13.8
12%
1.1
DE
Fresenius Medical Care AG
XMUN:FME
16.4
11%
1.5
US
Laboratory Corporation of America Holdings
NYSE:LH
17.2
18%
1
US
Quest Diagnostics Inc
NYSE:DGX
15.9
9%
1.8
DE
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
9.7
11%
0.9
US
Guardant Health Inc
NASDAQ:GH
Negative Multiple: -26.6 N/A N/A
US
DaVita Inc
NYSE:DVA
9.7
5%
1.9
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett